NeuroOne Partners with RBC Medical Innovations

NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and high-definition solutions to improve patient outcomes and reduce procedural costs.

FREMONT CA: NeuroOne Medical Technologies Corporation, a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced that it has executed an agreement with RBC Medical Innovations to develop and manufacture a proprietary radiofrequency (RF) generator for use with NeuroOne's combination recording and ablation electrode that is being designed to both record brain activity and ablate brain tissue using the same electrode.

Dave Rosa, President, and CEO of NeuroOne Medical Technologies Corporation, says, "RBC is a well-respected firm with over 25 years of design, development and manufacturing of differentiated medical devices with some of the world's largest and most innovative companies. We believe this partnership will allow NeuroOne to offer a proprietary complete system combining our game-changing combination ablation electrode with the hardware and software required to perform these procedures.